SignalXSignalX

HROW HARROW, INC.

Q3 2025 10-Q
Filed: Nov 10, 2025Period ending Sep 30, 2025
Health Care
Pharmaceutical PreparationsSEC EDGAR
HARROW, INC. Overview

HARROW, INC. (HROW) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 10, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q3 2025 10-Q

Risk Factors

  • • New risk: U.S. government shutdown starting Oct 1, 2025 causing FDA, CMS, SEC staffing cuts, delaying product approvals, reimbursement, and capital access
  • • Updated legal risk: Ongoing FDA inspections and warning letters (latest May 2023, 2024), with voluntary recalls and remediation raising compliance scrutiny
+3 more insights

Get deeper insights on HARROW, INC.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.